SNN

SMITH & NEPHEW PLC

OTC · Orthopedic, Prosthetic & Surgical Appliances & Supplies · CIK 0000845982
$30.61 -0.78% $13.0B
Vol
Market Cap$13.0B
Cap SizeLarge Cap
Analyst ConsensusBuy (54%)
Inst. Holders6 funds
Inst. Value$160.6M
Inst. Activity1 buys / 0 sells
Press Releases2
Exchange OTC·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·CIK 0000845982·Prev Close $30.85

Recent Activity

Inst.
BANK OF AMERICA CORP — ADD
1,417,062 shares ($46.5M)
Inst.
BANK OF AMERICA CORP — DOUBLED
987,274 shares ($35.8M)
Jun 4, 2026 short_volume
Short Volume: SNN — 69.6% short (0.6M / 0.8M)
Short: 563,937 | Exempt: 35 | TRF Vol: 809,839 | Short Ratio: 69.6% | Off-exchange volume (dark pool
Jun 1, 2026 Press
Smith+Nephew announced the US launch of the next-generation LEAF Patient Monitoring System, a cloud-based platform using
Impact 5/10
Mar 2, 2026 Press
Smith+Nephew announced its enhanced rotator cuff repair portfolio at the 2026 AAOS Annual Meeting, featuring the Tendon
Impact 7/10

Price Targets

$34.99 +14.3% upside Buy
Current $30.61 Low $30.00 Median $35.11 High $40.00 5 analysts
$30.00 $40.00

Analyst Ratings

Hold54% buy · 24 analysts
6Strong Buy
7Buy
11Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 11, 2026 Canaccord Genuity MAINTAIN Hold → Hold
Mar 5, 2026 Canaccord Genuity MAINTAIN Hold → Hold

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current FY $1.94 ▼ -5.2% $1.10 — $2.27 -5% YoY 4
Next FY $2.18 ▲ +4.3% $1.22 — $2.56 12% YoY 4

Top Institutional Holders

FundValueMove
MORGAN STANLEY$58.7MADD
BANK OF AMERICA CORP$46.5MADD
CAUSEWAY CAPITAL MANAGEMENT LLC$19.8MTRIM
FMR LLC$17.9M
WELLS FARGO & COMPANY/MN$15.4M
6 institutional holders with $160.6M total value (4,895,220 shares) as of 2025-Q4. Top holders: MORGAN, BANK, CAUSEWAY. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1MORGAN STANLEY1,789,470$58.7M36.6%ADD +51.0%
2BANK OF AMERICA CORP /DE/1,417,062$46.5M28.9%ADD +43.5%
3CAUSEWAY CAPITAL MANAGEMENT LLC603,812$19.8M12.3%TRIM -30.3%
4FMR LLC546,633$17.9M11.2%
5WELLS FARGO & COMPANY/MN470,471$15.4M9.6%
6CHARLES SCHWAB INVESTMENT MANAGEMENT INC67,772$2.2M1.4%ADD +51.1%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/ADD987,2741,417,062+43.5%$46.5M2025-Q4
BANK OF AMERICA CORP /DE/DOUBLED411,608987,274+139.9%$35.8M2025-Q3
CAUSEWAY CAPITAL MANAGEMENT LLCTRIM821,008572,532-30.3%$20.8M2025-Q3
RENAISSANCE TECHNOLOGIES LLCEXIT96,2500-100.0%$0.002025-Q3
MORGAN STANLEYADD1,302,4091,966,339+51.0%$60.2M2025-Q2
CAUSEWAY CAPITAL MANAGEMENT LLCADD607,357821,008+35.2%$25.1M2025-Q2
BANK OF AMERICA CORP /DE/DOUBLED150,717411,608+173.1%$12.6M2025-Q2
UBS Group AGADD104,536149,266+42.8%$4.6M2025-Q2
RENAISSANCE TECHNOLOGIES LLCNEW96,250$2.9M2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD35,89054,233+51.1%$1.7M2025-Q2
CAUSEWAY CAPITAL MANAGEMENT LLCADD480,888607,357+26.3%$17.2M2025-Q1
CITADEL ADVISORS LLCADD103,829194,388+87.2%$5.5M2025-Q1
CAUSEWAY CAPITAL MANAGEMENT LLCNEW480,888$11.8M2024-Q4
UBS Group AGDOUBLED44,204134,105+203.4%$3.3M2024-Q4
CITADEL ADVISORS LLCADD79,711103,829+30.3%$2.6M2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW27,199$847.0K2024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

Current analyst consensus: Hold (54% buy). Based on 24 analysts: 6 strong buy, 7 buy, 11 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$34.99 mean target +14.3% upside Buy (3.00)
$30.00 Low $40.00 High
MetricValue
Current Price$30.61
Target Low$30.00
Target Mean$34.99
Target Median$35.11
Target High$40.00
# Analysts5
RecommendationBuy (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-03-31
$0.00 $0.00 $0.00 $1.5B 5.5%
Next Q
2026-06-30
$0.00 $0.00 $0.00 $1.6B 6.2%
Current FY
2026-12-31
$1.94 $1.10 $2.27 -4.7% -5.2% 1↑ 0↓ $6.6B 6.7% 4
Next FY
2027-12-31
$2.18 $1.22 $2.56 12.1% +4.3% 1↑ 1↓ $7.0B 5.7% 4
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 11, 2026 Canaccord Genuity MAINTAIN Hold Hold
Mar 5, 2026 Canaccord Genuity MAINTAIN Hold Hold

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202667110054%
May 1, 202667110054%
Apr 1, 202666111050%
Mar 1, 202676101054%
Feb 1, 202677100058%
Jan 1, 202676110054%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 4, 2026
short_volume
Short Volume: SNN — 69.6% short (0.6M / 0.8M)
Short: 563,937 | Exempt: 35 | TRF Vol: 809,839 | Short Ratio: 69.6% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
m_and_a
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
<p>Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF<b><sup>♢</sup> </b>Patient
May 22, 2026
short_volume
Short Volume: SNN — 72.4% short (0.4M / 0.5M)
Short: 364,085 | Exempt: 5 | TRF Vol: 503,127 | Short Ratio: 72.4% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_volume
Short Volume: SNN — 68.6% short (0.4M / 0.6M)
Short: 407,941 | Exempt: 0 | TRF Vol: 594,748 | Short Ratio: 68.6% | Off-exchange volume (dark pool + OTC)
May 13, 2026
short_interest
FTD: SNN — 19,339 shares ($0.6M) failed to deliver
Settlement: 20260513, Price: $30.06, FTD Value: $581,330.34, SMITH & NEPHEW PLC ADS(NEW)(RP
May 12, 2026
short_interest
FTD: SNN — 95,958 shares ($2.8M) failed to deliver
Settlement: 20260512, Price: $29.10, FTD Value: $2,792,377.8, SMITH & NEPHEW PLC ADS(NEW)(RP
May 11, 2026
short_volume
Short Volume: SNN — 68.8% short (0.4M / 0.6M)
Short: 403,517 | Exempt: 0 | TRF Vol: 586,932 | Short Ratio: 68.8% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_interest
FTD: SNN — 17,856 shares ($0.5M) failed to deliver
Settlement: 20260511, Price: $29.95, FTD Value: $534,787.2, SMITH & NEPHEW PLC ADS(NEW)(RP
May 6, 2026
short_volume
Short Volume: SNN — 89.5% short (0.8M / 0.9M)
Short: 812,322 | Exempt: 623 | TRF Vol: 907,709 | Short Ratio: 89.5% | Off-exchange volume (dark pool + OTC)
May 5, 2026
other
Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026
<p>Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-le
May 5, 2026
short_volume
Short Volume: SNN — 77.7% short (0.4M / 0.5M)
Short: 413,211 | Exempt: 26 | TRF Vol: 531,585 | Short Ratio: 77.7% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_interest
FTD: SNN — 67,418 shares ($2.1M) failed to deliver
Settlement: 20260501, Price: $30.93, FTD Value: $2,085,238.74, SMITH & NEPHEW PLC ADS(NEW)(RP
Apr 24, 2026
short_interest
FTD: SNN — 32,181 shares ($1.0M) failed to deliver
Settlement: 20260424, Price: $31.92, FTD Value: $1,027,217.52, SMITH & NEPHEW PLC ADS(NEW)(RP
Apr 22, 2026
short_volume
Short Volume: SNN — 62.8% short (0.4M / 0.6M)
Short: 395,337 | Exempt: 0 | TRF Vol: 629,228 | Short Ratio: 62.8% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
short_interest
FTD: SNN — 27,513 shares ($0.9M) failed to deliver
Settlement: 20260421, Price: $34.21, FTD Value: $941,219.73, SMITH & NEPHEW PLC ADS(NEW)(RP